References
- Malchesky P. S., Asanuma Y., Smith J. W., Kayashima K., Zawicki I., Werynski A., Blumenstein M., Nose Y. Macromolecule Removal from Blood. Trans. Am. Soc. Artif. Intern. Organs 1981; 27: 439
- Bosch T. Current Status in Extracorporeal Immunomodulation: Immune Disorders. Artif. Organs 1996; 20: 902
- Toyka K. V., Drachman D. B., Griffin D. E., Pestronk A., Winkelstein J. A., Fischbeck K. H., Kao I. Myasthenia Gravis: Study of Humoral Immune Mechanisms by Passive Transfer to Mice. N. Engl. J. Med. 1977; 296: 125
- Newsom-Davis J., Pinching A. J., Vincent A., Wilson S. G. Function of circulating Antibody to Acetylcholine Receptor in Myasthenia Gravis: Investigation by Plasma Exchange. Neurology 1978; 28: 266
- Hawkey C. J., Newsom-Davis J., Vincent A. Plasma Exchange and Immunosuppressive Drug Treatment in Myasthenia Gravis: No Evidence for Synergy. J. Neurol. Neurosurg. Psychiatry 1981; 44: 469
- Seybold M. E., Lindstrom J. M. Patterns of Acetylcholine Receptor Antibody Fluctuation in Myasthenia Gravis. Ann. NY Acad. Sci. 1981; 377: 292
- Somnier F. E., Langvad E. Plasma Exchange with Selective Immunoadsorption of Anti-Acetylcholine Receptor Antibodies. J. Neuroimmunol. 1989; 22: 123
- Fornadi L., Horvath R., Szobor A. Myasthenia Gravis: Treatment with Plasma Exchange Experiences over 10 Years. Acta Med. Hung. 1991; 48: 137
- Caüegaro L., Barbieri U., Denti E. Selective Detoxification: Hemoperfusion on Antiphenobarbital Antibody Immobilized on Solid Phase. Trans. Am. Soc. Artif. Intern. Organs 1981; 27: 566
- Charlton B., Schindhelm K., Farrell P. C. Extracorporeal Antibody Removal Effect on Antibody Kinetics. Trans. Am. Soc. Artif. Intern. Organs 1985; 31: 711
- Terman D. S., Tavel T., Petty D., Tavel A., Harbeck R., Buffaloe G., Carr R. Specific Removal of Bovine Serum Albumin (BSA) Antibodies in vivo by Extracorporeal Circulation over BSA Immobilized on Nylon Microcapsules. J. Immunol. 1976; 116: 1337
- Hinman C. L., Green C. L., Denno D., Rauch H. C., Hudson R. A. Affinity Chromatographic Purification of Antibody Subsets Depends on the Mode of Crosslinking of Antigen to the Affinity Matrix. Mol. Immunol. 1985; 22: 681
- Hinman C. L., Dambach G. E., Hudson R. A., Rauch H. C. Response to Gallamine: An Indicator of Diminished Neuromuscular Function in Experimental Autoimmune Myasthenia Gravis. J. Neurosci. Res. 1985; 14: 271
- Hinman C. L., Hudson R. A., Burek C. L., Goodlow G., Rauch H. C. An Enzyme-Linked Immunosorbent Assay for Antibody Against Acetylcholine Receptor. J. Neurosci. Meth. 1983; 9: 141
- Berta E., Confalonieri P., Simoncini O., Bernardi G., Busnach G., Mantegazza R., Cornelio F., Antozzi C. Removal of Antiacetylcholine Receptor Antibodies by Protein-A Immunoadsorption in Myasthenia Gravis. Int. J. Artif. Organs 1994; 17: 603
- Grob D., Simpson D., Mitsumoto H., Hoch B., Mokhtarian F., Bender A., Greenberg M., Koo A., Nakayama S. Treatment of Myasthenia Gravis by Immunoadsorption of Plasma. Neurology 1995; 45: 338
- Blom R. J., Kuks J. B., Westerterp-Maas A., Oosterhuis H. J. Favorable Results of Plasmapheresis in Severe Myasthenia Gravis. Ned. Tijdschr. Geneeskd. 1997; 14: 381
- Brown R. M., Krolick K. A. Selective Idiotype Suppression of an Adoptive Secondary Anti-Acetylcholine Receptor Antibody Response by Immunotoxin Treatment Before Transfer. J. Immunol. 1988; 140: 893